(Hypertension. 1999;34:514-519.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
From the Department of Pharmacology, Tsukuba Research Institute, Banyu Pharmaceutical Co Ltd (T.I., H.O., M.O., N.K., R.N., T.K., M.N.); Cardiovascular Division, Department of Internal Medicine, Institute of Clinical Medicine, University of Tsukuba (S.M., T.M.), Ibaraki, Japan; and Department of Cardiovascular Pharmacology, Merck Research Laboratories (P.K.S.S.), West Point, Penn.
Correspondence to Masaru Nishikibe, PhD, Department of Pharmacology, Development Research Laboratories, Tsukuba Research Institute, Banyu Pharmaceutical Co Ltd, Okubo 3, Tsukuba, Ibaraki 300-2611, Japan. E-mail niskbems{at}banyu.co.jp
AbstractThe purpose of the
present experiment was to study the
pathophysiological roles of endothelin-1 (ET-1) in
salt-sensitive hypertension with the use of Dahl salt-sensitive (DS)
and salt-resistant (DR) rats. PreproET-1 mRNA expression
was determined by reverse transcriptionpolymerase chain reaction. In
the kidney, expression of preproET-1 mRNA was greater in DS rats on a
normal salt diet compared with DR rats of the same age. In DS rats, the
level of preproET-1 mRNA expression in kidney had a significant
correlation with systolic blood pressure. The expression of
preproET-1 mRNA in aorta and kidney was increased by 3-week high salt
intake in DS rats but not in DR rats. Expression of preproET-1 mRNA and
ET-1 levels in left ventricle was exaggerated by high salt intake in DS
rats. However, there was no significant difference in plasma ET-1
levels between DS and DR rats regardless of salt intake. Pressor
response curves for ET-1 in DS rats with or without high salt intake
were significantly shifted to the left compared with those in DR rats.
A single oral dose (3 to 10 mg/kg) of J-104132 (L-753 037), a potent,
orally active mixed endothelin A and B
(ETA/ETB) receptor antagonist,
reduced blood pressure to normotensive levels in DS rats with high salt
intake, and its action was maintained for
24 hours. In DS rats with
normal salt intake, J-104132 (10 mg/kg) slightly but significantly
decreased blood pressure. DR rats did not show obvious depressor
responses to J-104132 (10 mg/kg) regardless of salt intake. These
results suggest that ET-1 acts as one of the
pathophysiological factors in the development and
maintenance of salt-sensitive hypertension, and a mixed
ETA/ETB receptor antagonist could
be useful in the treatment for salt-sensitive hypertension.
Key Words: endothelin hypertension rats, Dahl kidney receptors, endothelin
This article has been cited by other articles:
![]() |
M. P. Schneider, E. W. Inscho, and D. M. Pollock Attenuated vasoconstrictor responses to endothelin in afferent arterioles during a high-salt diet Am J Physiol Renal Physiol, April 1, 2007; 292(4): F1208 - F1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Quaschning, F. Voss, K. Relle, P. Kalk, N. Vignon-Zellweger, T. Pfab, C. Bauer, F. Theilig, S. Bachmann, A. Kraemer-Guth, et al. Lack of Endothelial Nitric Oxide Synthase Promotes Endothelin-Induced Hypertension: Lessons from Endothelin-1 Transgenic/Endothelial Nitric Oxide Synthase Knockout Mice J. Am. Soc. Nephrol., March 1, 2007; 18(3): 730 - 740. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chansel, M. Ciroldi, S. Vandermeersch, L. F Jackson, A.-M. Gomez, D. Henrion, D. C. Lee, T. M. Coffman, S. Richard, J.-C. Dussaule, et al. Heparin binding EGF is necessary for vasospastic response to endothelin FASEB J, September 1, 2006; 20(11): 1936 - 1938. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D'Angelo, J. S. Pollock, and D. M. Pollock In vivo evidence for endothelin-1-mediated attenuation of {alpha}1-adrenergic stimulation Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1251 - H1258. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. M. Herrera, L. R. B. Ponce, P. D. Bagamasbad, B. D. VanPelt, T. Didishvili, and N. Ruiz-Opazo Embryonic lethality in Dear gene-deficient mice: new player in angiogenesis Physiol Genomics, November 17, 2005; 23(3): 257 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. del Villar, C. J. G. Alonso, C. A. Feldstein, L. A. Juncos, and J. C. Romero Role of Endothelin in the Pathogenesis of Hypertension Mayo Clin. Proc., January 1, 2005; 80(1): 84 - 96. [Abstract] [PDF] |
||||
![]() |
R. A. Fenton, C.-L. Chou, S. Ageloff, W. Brandt, J. B. Stokes, and M. A. Knepper Increased collecting duct urea transporter expression in Dahl salt-sensitive rats Am J Physiol Renal Physiol, July 1, 2003; 285(1): F143 - F151. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Ballew, S. W. Watts, and G. D. Fink Effects of Salt Intake and Angiotensin II on Vascular Reactivity to Endothelin-1 J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 345 - 350. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |